199 related articles for article (PubMed ID: 9864268)
1. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
Bonhaus DW; Chang LK; Kwan J; Martin GR
J Pharmacol Exp Ther; 1998 Dec; 287(3):884-8. PubMed ID: 9864268
[TBL] [Abstract][Full Text] [Related]
2. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
Slipetz DM; O'Neill GP; Favreau L; Dufresne C; Gallant M; Gareau Y; Guay D; Labelle M; Metters KM
Mol Pharmacol; 1995 Aug; 48(2):352-61. PubMed ID: 7651369
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.
Steffens M; Engler C; Zentner J; Feuerstein TJ
Br J Pharmacol; 2004 Apr; 141(7):1193-203. PubMed ID: 14993102
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
[TBL] [Abstract][Full Text] [Related]
5. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.
Rhee MH; Bayewitch M; Avidor-Reiss T; Levy R; Vogel Z
J Neurochem; 1998 Oct; 71(4):1525-34. PubMed ID: 9751186
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
8. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
Lau AH; Chow SS
Eur J Pharmacol; 2003 Mar; 464(2-3):229-35. PubMed ID: 12620517
[TBL] [Abstract][Full Text] [Related]
9. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
[TBL] [Abstract][Full Text] [Related]
10. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
11. CB1 cannabinoid receptor-mediated cell migration.
Song ZH; Zhong M
J Pharmacol Exp Ther; 2000 Jul; 294(1):204-9. PubMed ID: 10871313
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
Kim D; Thayer SA
J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
15. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Nilsson O; Fowler CJ; Jacobsson SO
Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
McAllister SD; Griffin G; Satin LS; Abood ME
J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process.
Deadwyler SA; Hampson RE; Mu J; Whyte A; Childers S
J Pharmacol Exp Ther; 1995 May; 273(2):734-43. PubMed ID: 7538581
[TBL] [Abstract][Full Text] [Related]
19. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
[TBL] [Abstract][Full Text] [Related]
20. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
Bosier B; Hermans E; Lambert DM
Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]